Latest Breaking News On - பென்சில்வேனியா பெரல்மேன் பள்ளி - Page 3 : comparemela.com

By Mike Cummings July 30, 2021 Share this with FacebookShare this with TwitterShare this with LinkedInShare this with EmailPrint this (© stock.adobe.com) Access to clinical-trial data helps doctors make informed prescribing decisions and promotes good science, but a new study co-authored by Yale researchers reveals that few pharmaceutical companies are fully transparent about the data behind the products they develop. The study also shows that large companies are far more transparent than smaller ones. The study, published in The BMJ Open (British Medical Journal), assessed the data-sharing practices of 42 pharmaceutical companies for clinical trials of 40 novel drugs and 22 biologics products, such as vaccines, derived from living organisms approved by the U.S. Food and Drug Administration in 2016 and 2017. The evaluation was performed using the Good Pharma Scorecard, a tool developed by researchers at Yale, Stanford, and Bioethics International which consists of transpare

United kingdomDeborah lincowCary grossJennifer millerCatherine yangBioethics internationalYale school of medicineUniversity of pennsylvania perelman school medicineDrug administrationBritish medical journalGood pharma scorecardYale schoolSydney axsonStanford university schoolPennsylvania perelman schoolArnold ventures